Transform Your Specialty Practice with McKesson's Lynx® Drug Inventory Management System

About Lynx

McKesson's Specialty Drug Inventory Management System, particularly the Lynx® platform, stands out as a transformative solution for specialty practices navigating the complexities of injectable and infusible medication therapy. With its web-based architecture, Lynx offers unparalleled accessibility, allowing multiple users across various locations to manage inventory seamlessly. This flexibility is crucial for practices that require real-time data and collaboration among staff.

One of the most impressive features of Lynx is its ability to enhance charge capture significantly. By integrating directly with billing applications, it ensures that every billable charge is accounted for, which can lead to substantial financial benefits—averaging an additional $70,000 per physician annually. This capability not only improves revenue but also streamlines the billing process, reducing the time required to submit claims by 28%.

Moreover, Lynx empowers practices to optimize their inventory management. The system's reporting and analytics tools help eliminate excess inventory and minimize drug wastage, ultimately improving cash flow. The promise of a 50% reduction in days in on-hand inventory is a compelling statistic that speaks to the efficiency gains practices can expect.

The user-friendly interface and customizable medication labels further enhance the system's appeal, making it easier for staff to identify and manage medications accurately. Additionally, the modular cabinet design offers flexibility to meet the unique needs of each practice, ensuring secure and efficient storage solutions.

McKesson's Lynx® inventory management system is a robust tool that not only addresses the challenges of specialty drug management but also drives significant improvements in operational efficiency and financial performance. For specialty practices looking to enhance their medication therapy delivery, Lynx represents a smart investment in their future success.